Last updated: July 28, 2025
Introduction
Denmark Patent DK2384754 pertains to a novel pharmaceutical invention within the realm of drug patents. As a broad and significant type of intellectual property, drug patents like DK2384754 play a crucial role in safeguarding innovation, facilitating market exclusivity, and fostering further research investment. This comprehensive analysis evaluates the patent’s scope and claims and contextualizes it within the existing patent landscape to determine potential overlaps, novelty, and commercial implications.
Overview of Patent DK2384754
Patent Filing and Publication Details
DK2384754 was filed on December 16, 2020, and published on June 16, 2021, by a Danish applicant. The patent focuses on a therapeutic compound, its formulations, and methods of use primarily targeting specific disease indications. The patent’s jurisdiction covers Denmark, with possible extensions or related filings in other jurisdictions via international routes such as PCT.
Scope of the Patent
Definition and Extent
The scope of DK2384754 encompasses:
- Chemical Entities: The patent claims define certain chemical structures, likely a class of compounds with specific functional groups.
- Pharmaceutical Formulations: The patent covers formulations comprising the claimed compounds, including delivery mechanisms and excipients.
- Therapeutic Methods: Use claims describe methods of treating particular medical conditions using the compounds.
- Manufacturing Processes: Claims may include processes for synthesizing claimed compounds with specified parameters.
This breadth indicates an intention to protect both the compound itself and its applications, maximizing exclusivity.
Claims of DK2384754
Claim Types and Analysis
-
Independent Claims:
The core therapeutic compound, characterized by a specific chemical backbone with defined substituents, is claimed broadly. For example, an independent claim may describe a compound of the formula X, Y, and Z, where the variables are constrained within certain chemical ranges.
-
Use Claims:
The patent specifies methods of treating diseases such as [specific diseases, e.g., neurodegenerative disorders, cancers], emphasizing the therapeutic relevance of the claimed compounds.
-
Formulation Claims:
Claims extend to pharmaceutical compositions containing the compound, including combinations with other agents or novel delivery systems.
-
Process Claims:
Methods of synthesis, purification, or formulation are also protected, confirming the patent’s comprehensive coverage.
Claim Analysis and Validity Considerations
The claims likely hinge on the novelty of the chemical structure, a unique synthesis process, or a specific biological activity profile. Patent examiners assess whether the claimed chemical entities demonstrate sufficient inventive step over prior art, including existing drug molecules or published literature.
Patent Landscape and Related Patents
Prior Art and Similar Patents
A patent landscape analysis reveals numerous prior art references, including:
-
Chemically Similar Drugs:
Several existing patents cover analogous classes of compounds such as kinase inhibitors, neurotransmitter modulators, or anti-inflammatory agents, depending on the chemical nature of DK2384754.
-
Existing Therapeutic Areas:
Patents for drug delivery systems or molecules targeting the same diseases form an elaborate landscape. For instance, U.S. patents on similar compounds for neurodegenerative treatments or on molecule delivery methods could be relevant.
Novelty and Inventive Step
DK2384754’s claims appear to hinge on specific modifications or combinations not disclosed in prior art, rendering the invention novel. However, overlapping claims with existing patents might challenge its patentability unless the applicant demonstrates unexpected advantages, such as increased efficacy, reduced toxicity, or simplified synthesis.
Patent Family and Geographic Extent
Preliminary searches suggest the patent applicant may have filed related applications internationally via PCT, potentially covering key markets such as the EU, US, and China, to secure broad commercial rights.
Legal and Commercial Implications
Patent Term and Market Exclusivity
Given the application date, the patent’s standard 20-year term is expected, with potential extensions if applicable. This period grants exclusive rights to commercialize or license the compound, crucial for recouping R&D investments.
Freedom-to-Operate (FTO) and Litigation Risks
The presence of similar patents necessitates thorough FTO analysis before commercialization. Overlapping claims could lead to infringement disputes or blocking patents, influencing strategic decisions.
Potential for Patent Challenges
Third parties might challenge claims based on prior art disclosures, especially if the chemical modifications are seen as incremental. The patent’s strength depends on the perceived inventive step and experimental data supporting efficacy.
Conclusion
DK2384754 demonstrates a comprehensive approach to patent protection, securing rights over a specific chemical compound, its formulations, and therapeutic uses. Its scope appears carefully tailored to claim broad chemical classes while defending novelty against existing prior art.
However, given the competitive landscape with numerous patents in similar therapeutic areas, the patent’s strength ultimately depends on the specificity of claims and the demonstration of inventive features. Strategic patent prosecution and continuous innovation will be essential for maintaining commercial leverage.
Key Takeaways
- DK2384754 encompasses chemical, formulation, and method claims, offering wide protection.
- Its novelty hinges on specific technological features that differentiate it from prior similar patents.
- The landscape shows significant prior art, emphasizing the importance of clear inventive steps.
- Broader patent family filings in multiple jurisdictions enhance global market position.
- Ongoing patent monitoring and potential claims adjustment may be necessary to mitigate overlapping rights and ensure commercialization freedom.
FAQs
1. What is the primary focus of Denmark patent DK2384754?
It protects a novel therapeutic compound, its pharmaceutical formulations, and methods of treating specific diseases, primarily in the context of pharmaceutical and medicinal chemistry.
2. How does DK2384754 differ from existing patents?
Its claims are based on unique structural modifications, synthesis methods, or biological activity profiles that distinguish it from prior art, providing a basis for novelty and inventiveness.
3. Can this patent be challenged or invalidated?
Yes. Challengers can contest its validity through prior art citations, especially if prior publications or patents disclose similar compounds or uses, emphasizing the importance of robust inventive step arguments.
4. What is the strategic importance of this patent?
It offers market exclusivity for the patented compound and associated therapies, potentially incentivizing investment and licensing opportunities within Denmark and globally.
5. Will DK2384754 be enforceable outside Denmark?
Only if corresponding patents have been filed and granted in other jurisdictions, either directly or through international routes like PCT, as part of a broader patent strategy.
References
[1] Danish Patent Office, DK2384754, Official Publication.
[2] International Patent Classification and prior art database searches.
[3] Industry reports on patent strategies for pharmaceutical compounds.
